Matarin Capital Management Has Cut Intel (INTC) Stake; Kiltearn Partners Llp Has Increased Cvs Health (CVS) Stake

January 11, 2018 - By Marie Mckinney

Matarin Capital Management Llc decreased Intel Corporation (INTC) stake by 15.34% reported in 2017Q3 SEC filing. Matarin Capital Management Llc sold 23,560 shares as Intel Corporation (INTC)’s stock declined 2.96%. The Matarin Capital Management Llc holds 130,055 shares with $4.95 billion value, down from 153,615 last quarter. Intel Corporation now has $203.16 billion valuation. The stock increased 2.14% or $0.91 during the last trading session, reaching $43.41. About 26.05 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since January 11, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Kiltearn Partners Llp increased Cvs Health Corp (CVS) stake by 242.03% reported in 2017Q3 SEC filing. Kiltearn Partners Llp acquired 1.46 million shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Kiltearn Partners Llp holds 2.07M shares with $167.94M value, up from 603,800 last quarter. Cvs Health Corp now has $80.05B valuation. The stock increased 2.04% or $1.58 during the last trading session, reaching $79.02. About 7.15 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 11, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment is 1.03 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 52 investors sold INTC shares while 663 reduced holdings. only 127 funds opened positions while 608 raised stakes. 3.05 billion shares or 0.19% more from 3.05 billion shares in 2017Q2 were reported. Cardinal Capital Management stated it has 1.98% in Intel Corporation (NASDAQ:INTC). Alpha Windward Lc reported 8,233 shares. Kidder Stephen W stated it has 2.55% of its portfolio in Intel Corporation (NASDAQ:INTC). Architects holds 4,136 shares or 0.29% of its portfolio. 10,909 are owned by Bankshares Of Nova Scotia. Clifford Swan Investment Counsel Lc owns 528,559 shares. Ballentine Ltd Llc owns 32,438 shares. Janney Montgomery Scott Limited Liability Corporation has 1.28 million shares for 0.56% of their portfolio. Stillwater Management Ltd Liability invested in 0.82% or 47,256 shares. Meyer Handelman Company invested in 810,709 shares. Ashfield Capital Prtnrs Limited Liability Company stated it has 1.72% in Intel Corporation (NASDAQ:INTC). Cullinan Associates owns 0.96% invested in Intel Corporation (NASDAQ:INTC) for 326,348 shares. Putnam Investments Ltd Limited Liability Company has invested 0.27% of its portfolio in Intel Corporation (NASDAQ:INTC). Royal Bankshares Of Canada invested in 0.28% or 15.21 million shares. Hendershot Invs, Virginia-based fund reported 2,800 shares.

Analysts await Intel Corporation (NASDAQ:INTC) to report earnings on January, 25. They expect $0.86 EPS, up 8.86% or $0.07 from last year’s $0.79 per share. INTC’s profit will be $4.02B for 12.62 P/E if the $0.86 EPS becomes a reality. After $1.01 actual EPS reported by Intel Corporation for the previous quarter, Wall Street now forecasts -14.85% negative EPS growth.

Matarin Capital Management Llc increased Photronics Inc. (NASDAQ:PLAB) stake by 17,044 shares to 127,368 valued at $1.13 billion in 2017Q3. It also upped Deluxe Corporation (NYSE:DLX) stake by 15,400 shares and now owns 112,377 shares. Central Valley Community Bancorp (NASDAQ:CVCY) was raised too.

Since July 31, 2017, it had 0 buys, and 10 selling transactions for $31.43 million activity. The insider Smith Stacy J sold 58,629 shares worth $2.08M. On Monday, October 30 YOFFIE DAVID B sold $1.35M worth of Intel Corporation (NASDAQ:INTC) or 30,000 shares. $3.99M worth of Intel Corporation (NASDAQ:INTC) shares were sold by BRYANT ANDY D. RENDUCHINTALA VENKATA S M sold 1,424 shares worth $51,834. 61,860 shares were sold by Krzanich Brian M, worth $2.40M on Monday, October 2. Bryant Diane M also sold $25,360 worth of Intel Corporation (NASDAQ:INTC) shares.

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 34 have Buy rating, 5 Sell and 15 Hold. Therefore 63% are positive. Intel Corporation had 207 analyst reports since August 7, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained it with “Buy” rating and $43.0 target in Monday, September 11 report. Credit Suisse maintained it with “Outperform” rating and $40 target in Thursday, July 21 report. The rating was maintained by Nomura with “Buy” on Wednesday, October 19. JP Morgan initiated it with “Overweight” rating and $40 target in Tuesday, January 12 report. Morgan Stanley upgraded Intel Corporation (NASDAQ:INTC) on Friday, January 27 to “Equal-Weight” rating. On Tuesday, January 12 the stock rating was upgraded by Mizuho to “Buy”. The firm has “Hold” rating by Credit Suisse given on Thursday, January 4. The firm has “Outperform” rating by Northland Capital given on Thursday, October 8. Cowen & Co maintained it with “Market Perform” rating and $59.0 target in Thursday, October 22 report. The firm earned “Sector Perform” rating on Monday, January 18 by RBC Capital Markets.

Since August 16, 2017, it had 0 insider purchases, and 7 insider sales for $58.32 million activity. Foulkes Helena also sold $3.22M worth of CVS Health Corporation (NYSE:CVS) on Friday, September 15. Another trade for 237,078 shares valued at $18.88M was sold by Denton David M. $7.19M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Moriarty Thomas M. SWIFT RICHARD J also sold $199,050 worth of CVS Health Corporation (NYSE:CVS) shares. Roberts Jonathan C also sold $7.13 million worth of CVS Health Corporation (NYSE:CVS) on Monday, September 18. MERLO LARRY J had sold 241,150 shares worth $20.03M.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Levin Capital Strategies Lp reported 8,110 shares or 0.01% of all its holdings. Moreover, Jane Street Lc has 0.03% invested in CVS Health Corporation (NYSE:CVS). Alps Advsr stated it has 17,497 shares. Camarda Fincl Advsr Limited Co holds 0% or 55 shares. Charter Tru holds 20,965 shares or 0.21% of its portfolio. Robeco Institutional Asset Management Bv holds 397,309 shares. Cortland Mo holds 500,926 shares. Ray Gerald L & stated it has 35,110 shares. Mastrapasqua Asset Mngmt invested in 4,275 shares. Arrowstreet Cap LP stated it has 93,800 shares or 0.02% of all its holdings. Welch Capital Prtn Limited Liability accumulated 72,954 shares. Tocqueville Asset Management Lp holds 14,018 shares or 0.01% of its portfolio. Citadel Advisors Ltd Limited Liability Company invested in 0.02% or 335,581 shares. Provise Management Grp Limited Co accumulated 24,700 shares. 107,847 are owned by Highland Capital Mgmt Limited Liability Corporation.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. As per Friday, September 15, the company rating was maintained by Jefferies. Jefferies maintained CVS Health Corporation (NYSE:CVS) rating on Wednesday, October 18. Jefferies has “Hold” rating and $86.0 target. Leerink Swann maintained it with “Buy” rating and $90.0 target in Monday, January 8 report. On Monday, December 4 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Robert W. Baird on Friday, October 27. Robert W. Baird maintained the stock with “Hold” rating in Thursday, January 4 report. The firm has “Hold” rating by Needham given on Friday, September 8. Needham maintained CVS Health Corporation (NYSE:CVS) on Monday, December 4 with “Buy” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Friday, June 9. The rating was maintained by Oppenheimer on Thursday, December 17 with “Outperform”.